Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

LGC licenses first DNA test for response to schizophrenia treatment from the Institute of Psychiatry, King’s College London

LGC, Europe's leading independent analytical laboratory providing advanced chemical, biochemical and forensic analysis, has announced an exclusive agreement with King’s College London to offer the first pharmacogenetic screening service which will predict whether a patient with schizophrenia will respond positively to the antipsychotic drug clozapine.

8 Nov 2005

What a joke! women laugh more than men

Just in case more evidence was needed that men and women are different just look at some cartoons, because according to a new Stanford University School of Medicine study, gender affects the way a person's brain responds to humour.

8 Nov 2005

Antisocial behavior in children associated with gene variant and environmental risk factors

For children with attention deficit hyperactivity disorder (ADHD), possessing a variant of a gene involved in brain signaling may predict antisocial behavior and increase susceptibility to the effects of lower birth weight, according to a study in the November issue of Archives of General Psychiatry.

7 Nov 2005

Anxiety disorders increase risk of suicidal thoughts

A pre-existing anxiety disorder significantly increases the risk of a subsequent onset of suicidal thoughts and suicide attempts, according to a study in the November issue of Archives of General Psychiatry.

7 Nov 2005

Methylphenidate shows promise for hyperactivity associated with autism

Medication commonly used to treat attention-deficit hyperactivity disorder (ADHD) may be effective for treatment of hyperactivity symptoms in children with autism and related pervasive developmental disorders, according to a study in the November issue of Archives of General Psychiatry.

7 Nov 2005

MRI helps early diagnosis of schizophrenia

Researchers may have discovered a new way that may ultimately assist in the early diagnosis of schizophrenia - by utilizing MRI to study the patient's brain.

7 Nov 2005

New York-Presbyterian Hospital offers Vagus Nerve Stimulation (VNS) Therapy

New York-Presbyterian Hospital/Columbia University Medical Center is the first in the greater New York City-area to offer Vagus Nerve Stimulation (VNS) Therapy as a long-term treatment specifically approved by the FDA for treatment-resistant depression (TRD).

7 Nov 2005

Young hockey player injuries studied - suprising findings

Unintentional collisions and falling into the boards cause more injuries in young hockey players than the practice of body checking, researchers at the University at Buffalo have found.

3 Nov 2005

Socioeconomic status determines life expectancy in HIV patients

HIV patients with a low socioeconomic status are likelier to die much more often than patients with higher levels of wealth and education, a new UCLA study has found.

3 Nov 2005

Environment is a major factor influencing the success of the addiction recovery

New research in monkeys suggests that, although living in an "enriched" environment can make someone less vulnerable to abusing cocaine, once started, extended drug abuse can eliminate the social advantage the abuser originally had.

30 Oct 2005

Type 2 diabetes and depression can be a fatal mix

Patients whose type 2 diabetes was accompanied by minor or major depression had higher mortality rates, compared to patients with type 2 diabetes alone, over the three-year period of a recent study in Washington state.

27 Oct 2005

FDA panel says approval for new depression drugs needs to be faster

According to a Food and Drug Administration (FDA) advisory panel, drug makers seeking U.S. approval of new drugs to treat major depression should not be required to first provide data on how well they work long-term.

26 Oct 2005

Depression raises disability risk

Depressed middle-aged adults are at four times greater risk for being unable to perform everyday tasks than their non-depressed peers, a Northwestern University study found.

25 Oct 2005

The face represents an important window into the influences of stress and emotion on health

A provocative new study has found that people who respond to stressful situations with angry facial expressions, rather than fearful expressions, are less likely to suffer such ill effects of stress as high blood pressure and high stress hormone secretion.

25 Oct 2005

Depression alone affects approximately 1.3 million Australian women ever year

Women's health problems, depression and child abuse represented a major health crisis in Australia, a seminar focusing on women and mental health over the weekend was told.

24 Oct 2005

Research has important implications for autism

New research from Melbourne's Howard Florey Institute helps to explain why children with autism spectrum disorders (autism) have problem-solving difficulties.

24 Oct 2005

Possible new directions for treatments for addiction to cocaine

Cocaine causes specific alterations in the brain's circuitry at a genetic level, including short-term changes that result in a high from the cocaine, as well as long-term changes seen in addiction, researchers from UT Southwestern Medical Center have found.

23 Oct 2005

Teens with missing part of a chromosome confirm genetic role in schizophrenia

A study in youth who are missing part of a chromosome is further implicating a suspect gene in schizophrenia.

23 Oct 2005

Dopamine link to psychiatric and neurological disorders

A gene that regulates dopamine levels in the brain is involved in the development of schizophrenia in children at high risk for the disorder, say researchers at the Stanford University School of Medicine, Lucile Packard Children's Hospital and the University of Geneva.

23 Oct 2005

Protein Oct-6 is not a biological marker for schizophrenia

The protein Oct-6 is not a biological marker for schizophrenia. The results of a study published today in the open access journal BMC Psychiatry contradict previous findings and show that Oct-6, a protein involved in neurodevelopment, is normally expressed in the adult brain and cannot be used to identify patients with schizophrenia.

23 Oct 2005